Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Jasper Therapeutics, Inc. (JSPR : NSDQ)

• Company Description    Jasper Therapeutics Inc., a biotechnology company focused on hematopoietic cell transplant therapies. Jasper Therapeutics Inc., formerly known as Amplitude Healthcare Acquisition Corporation, is based in REDWOOD CITY, Calif. Number of Employees: 25

• Price / Volume Information    Yesterday's Closing Price: $2.97 Daily Weekly Monthly 20 Day Moving Average: 68,329 shares Shares Outstanding: 37.87 (millions) Market Capitalization: $112.49 (millions) Beta: 0.52 52 Week High: $18.88 52 Week Low: $2.45 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 9.19% 19.64% 12 Week -34.72% -29.17% Year To Date -62.17% -55.01%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2200 BRIDGE PKWY SUITE #102 - REDWOOD CITY,CA 94065 USA ph: 650-549-1400 fax: - ir@jaspertherapeutics.com https://jaspertherapeutics.com

• General Corporate Information    Officers Ronald Martell - President; Chief Executive Officer William Lis - Chairman of the Board Jeet Mahal - Chief Financial Officer and Chief Business Officer Kurt von Emster - Director Christian W.Nolet - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 471871103 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/11/22 Share - Related Items Shares Outstanding: 37.87 Most Recent Split Date: (:1) Beta: 0.52 Market Capitalization: $112.49 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.37 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.30 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/11/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.65 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/22 - -73.06 12/31/21 - -94.39 09/30/21 - -201.97 ROA 03/31/22 - -42.32 12/31/21 - -37.09 09/30/21 - -32.52 Current Ratio 03/31/22 - 12.36 12/31/21 - 10.95 09/30/21 - 11.18 Quick Ratio 03/31/22 - 12.36 12/31/21 - 10.95 09/30/21 - 11.18 Operating Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Net Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Pre-Tax Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Book Value 03/31/22 - 1.80 12/31/21 - 1.84 09/30/21 - 2.08 Inventory Turnover 03/31/22 - - 12/31/21 - - 09/30/21 - - Debt-to-Equity 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - 0.00 Debt-to-Capital 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - 0.00

Powered by Zacks Investment Research ©